National Institute for Health and Care Excellence6d
International collaboration provides new guidance on the use of surrogate endpoints in cost-effectiveness analysis
NICE, in collaboration with other international health technology assessment agencies, has published a new report which ...
National Institute for Health and Care Excellence13h
In consultation: Guidance and quality standards
Marstacimab for treating severe haemophilia A or severe haemophilia B in people 12 years and over [ID6342] Draft guidance Technology appraisal guidance 6 February 2025 Capivasertib with fulvestrant ...
National Institute for Health and Care Excellence3d
Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals
A list of downloadable documents created during development.
National Institute for Health and Care Excellence3d
Transcatheter tricuspid valve replacement for the reduction of tricuspid regurgitation
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
National Institute for Health and Care Excellence8d
Maternal and child nutrition: nutrition and weight management in pregnancy, and nutrition in children up to 5 years
This guideline covers nutrition and weight management in pregnancy for anyone who may become pregnant, is planning to become pregnant or is already pregnant, and nutrition in children up to 5 years.
National Institute for Health and Care Excellence9d
Overweight and obesity management
This guideline covers the prevention and management of overweight, obesity and central adiposity in children, young people and adults. It brings together and updates all NICE's previous guidelines on ...
National Institute for Health and Care Excellence3d
Trans-venous embolisation for the treatment of Cerebrospinal fluid venous fistula (CSFVF) a cause of spontaneous intracranial hypotension (SIH)
Reason for decision Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in ...
National Institute for Health and Care Excellence9d
Planning and delivering overweight and obesity services and interventions
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
National Institute for Health and Care Excellence3d
Superior rectal artery embolisation for haemorrhoids
The National Institute for Health and Care Excellence (NICE) issued full guidance to the NHS in England, Wales, Scotland and Northern Ireland on Superior rectal artery embolisation for haemorrhoids in ...
National Institute for Health and Care Excellence9d
Behavioural overweight and obesity management interventions
People have the right to be involved in discussions and make informed decisions about their care, as described in NICE's information on making decisions about your care. Making decisions using NICE ...
National Institute for Health and Care Excellence8d
Andexanet alfa for reversing anticoagulation in people with intracranial haemorrhage (terminated appraisal)
NICE is unable to make a recommendation about the use in the NHS of andexanet alfa (Ondexxya) for reversing anticoagulation in adults with intracranial haemorrhage. This is because AstraZeneca did not ...
National Institute for Health and Care Excellence3d
Proposed changes to appeal period for technology appraisal and highly specialised technologies appeals
the recommendation is unreasonable in the light of the evidence submitted to NICE. NICE’s guide to the technology appraisal and highly specialised technologies appeal process sets out the arrangements ...